Avid Bioservices, Inc.
CDMO · NASDAQ
10/31/2024 | 7/31/2024 | 4/30/2024 | 1/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -16.7% | -6.5% | 27.1% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -6.1% | 14.2% | 12.8% | 7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -30.3% | -0.6% | -1.3% | -9.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -52% | -13.8% | -286.5% | -17.8% |
| EPS Diluted | -0.27 | -0.087 | -1.94 | -0.095 |
| % Growth | -210.3% | 95.5% | -1,944.3% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |